Opiant Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Opiant Pharmaceuticals Ownership

Who owns Opiant Pharmaceuticals?

Opiant Pharmaceuticals is owned by Indivior. It was acquired on November 14, 2022.

Opiant Pharmaceuticals Business Overview

Where is Opiant Pharmaceuticals headquartered?

Opiant Pharmaceuticals is headquartered in Santa Monica, California.

What is Opiant Pharmaceuticals’ revenue?

Opiant Pharmaceuticals disclosed revenue of 41M USD for 2021 and 27M USD for 2020.

How many employees does Opiant Pharmaceuticals have?

Opiant Pharmaceuticals has 37 employees.

What sector is Opiant Pharmaceuticals in?

Opiant Pharmaceuticals is a life science company.

When was Opiant Pharmaceuticals founded?

Opiant Pharmaceuticals was founded in 2005.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 291 acquisitions of life science companies in 2022, including 36 acquisitions by private equity firms, and 255 by strategics.

Opiant Pharmaceuticals

Opiant Pharmaceuticals, Inc.

233 Wilshirre Boulevard, Suite 400,
Santa Monica, California 90401
United States,
(310) 598-5410
www.opiant.com

Opiant Pharmaceuticals is a biopharmaceutical company developing treatments for addiction and drug overdose leveraging intranasal and injectable delivery technologies. Opiant Pharmaceuticals was founded in 2005 and is based in Santa Monica, California.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.